ANRO
Alto Neuroscience·NYSE
--
--(--)
--
--(--)
4.19 / 10
Netural
Assessment shows balanced fundamentals at 4.2/10. Constructive elements: Interest coverage ratio (EBIT / Interest expense) (%) and Revenue-MV, but headwinds are noted in Days sales outstanding and Asset-MV. Investment case: selective.
Analysis Checks(8/10)
Revenue-MV
Value-0.26
Score3/3
Weight20.17%
1M Return10.54%
Value-0.26
Score3/3
Weight20.17%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.72%
1M Return1.11%
Value78.47
Score2/3
Weight1.72%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
PB-ROE
Value-0.31
Score3/3
Weight21.80%
1M Return12.83%
Value-0.31
Score3/3
Weight21.80%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.66%
1M Return0.43%
Value92.66
Score2/3
Weight0.66%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight20.17%
1M Return10.54%
Value-0.26
Score3/3
Weight20.17%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.72%
1M Return1.11%
Value78.47
Score2/3
Weight1.72%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
PB-ROE
Value-0.31
Score3/3
Weight21.80%
1M Return12.83%
Value-0.31
Score3/3
Weight21.80%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.66%
1M Return0.43%
Value92.66
Score2/3
Weight0.66%
1M Return0.43%
Asset-MV
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Is ANRO undervalued or overvalued?
- ANRO scores 4.19/10 on fundamentals and holds a Fair valuation at present. Backed by its -35.78% ROE, 0.00% net margin, -7.59 P/E ratio, 4.24 P/B ratio, and 53.25% earnings growth, these metrics solidify its Netural investment rating.
